- Mild-moderate active ulcerative colitis:
- Adults: PO 800mg TDS *6/52 OR PO 1.6g TDS
- Adults: PO 800mg TDS *6/52 OR PO 1.6g TDS
-
- Children >5 years:
- 17-33kg: PO 36-71mg/kg/day divided BD *6/52. Max 1.2g/day
- 33- <54 kg: PO 37-61mg/kg/day divided BD *6/52. Max 2g/day
- 54-90 kg: PO 27-44mg/kg/day divided BD *6/52. Max 2.4 g/day
- Children >5 years:
- Remission maintenance of ulcerative colitis:
- PO 1.6g/day in divided doses
- PO 1.6g/day in divided doses
- Crohn’s disease (Off-label):
- PO 1.6g TDS
- Tablet:
- 400mg
- 500mg
- 800mg
- 1g
- 2g
- To be taken 1 hour before or 2 hours after meals
5-aminosalicyclic acid, anti-inflammatory agent
It is thought to block cyclooxygenase and inhibit prostaglandin production in the colon, exerting local anti-inflammatory effects
- Eructation
- Abdominal pain
- Nasopharyngitis
- Constipation
- Headache
- Dizziness
- Diarrhea
- Back pain
- Rash
- URI (peds patients)
- Vomiting
- Anemia (peds patients)
- Infection
- Dyspepsia
- Flu syndrome
- Nausea
- Colitis exacerbation
- Flatulence
- Elevated ALT/AST
- Fatigue (peds patients)
- Arthralgia
- GI bleeding
- Paresthesia
- Vision changes
- Nervousness
- Urinary frequency
- Photosensitivity
- Hypersensitivity to salicylates
- Influenza, varicella, or febrile viral infection (patients <20 years old)
- Upper GI obstruction risk
- Cidofovir
- Live varicella vaccine
Drug Status
Availability | Prescription only |
Pregnancy | Category B |
Breastfeeding | Use with caution |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Mesacol | 400mg | Tablet | 50’s | Sun Pharma | Sun Pharma |
Mesla | 800mg | Tablet | 30’s | Innocia Lifesciences | Wessex Pharma |
Pentasa | 500mg | Tablet | 100’s | Ferring International | Macnaughton Ltd |
Pentasa | 1g | Tablet | 100’s | Ferring International | Macnaughton Ltd |
Pentasa Xtend | 2g | Sachet | 100’s | Ferring International | Macnaughton Ltd |